Parkinson's UK Board of Trustees

Our Board of Trustees is the governing body of Parkinson's UK and is ultimately responsible for everything we do and how we do it.

The Board directs the affairs of the charity, ensuring that we are solvent, well run, and deliver charitable outcomes for the benefit of people affected by Parkinson's.

Mark Goodridge (Chair)

Mark Goodridge was appointed to the Parkinson's UK Board of Trustees in September 2009. He became vice chair in November 2013 and chair in December 2015.

Mark enjoyed a successful business career in the steel and petrochemical industries and is a former partner at Ernst and Young. Mark has run his own company for over 30 years, advising firms on improving their organisational effectiveness.

He has worked extensively with the boards and executive teams of not for profit, government and public organisations. Mark's work with charities has included Barrow Cadbury Trust, RSPB, Children in Need, The Carbon Trust, Energy Saving Trust and various housing trusts.

Mark also chairs the Board of Governors of a secondary school and advises the Woolf Institute in Cambridge for the study of relations between Jews, Christians and Muslims.

Mary Whyham MBE (Vice Chair)

Mary Whyham MBE was elected as a trustee in September 2015, and became vice chair in December 2015. She is also the chair of our Blackpool, Fylde and Wyre Branch.

Mary is a former board member in the NHS and has been a trustee of The National Association for the Care and Resettlement of Offenders, and the Society for Companion Animal Studies.

Mary's husband was diagnosed with Parkinson's in 2001. Mary's caring responsibilities have increased over the years, and she understands the importance of finding a cure for Parkinson's and the support needed for everyone affected by the condition.

Mary spent her working life in the public sector with nearly 34 years for the Probation Service in Lancashire, retiring in 2003. In 2001, she was appointed MBE for services to probation in Lancashire and the local community.

Kyle Alexander (Trustee from Northern Ireland)

Kyle Alexander was appointed by co-option to the Board of Trustees in August 2018, bringing a Northern Ireland presence to the board.

As an urban planner, Kyle has been chief executive and accounting officer of high profile public development corporations in Northern Ireland and brings experience in governance, business planning and project delivery. 

Kyle received an OBE in 2007 for services to regeneration in Northern Ireland, having overseen the transformation of Belfast's waterfront by Laganside Corporation. Having successfully managed the winding up of that organisation, he then led the establishment of the Maze Long Kesh Development Corporation, overseeing the regeneration of this politically sensitive site.

Throughout his career he has been committed to both 'people and place', engaging with local communities to ensure delivery of social outcomes. In recognition of his contribution he accepted the invitation to be a Fellow of the Royal Institute of Chartered Surveyors in 2015.

Kyle is a Belfast Harbour Commissioner with a particular interest in corporate social responsibility, a trustee of the community-led Connswater Community Greenway Trust in East Belfast and a trustee of The Waterways Community.

He was previously involved in international networks as a board member of the global urban development association INTA and a member of the European CABERNET brownfield regeneration network.

He is a trustee and elder of a local church and currently editor of the church magazine. Married and living in Lisburn, his interests include gardening, supporting Manchester United and playing with 2 young grandchildren.

Kyle was diagnosed with Parkinson's in 2016 and welcomes the opportunity to help make a difference for other people living with the condition. 

David Burn

Professor David Burn took up the position of Pro-Vice-Chancellor of the Faculty of Medical Sciences at Newcastle University on 1 February 2017.

The Faculty delivers impact through excellence in, and close integration of, research, teaching and engagement across 7 research institutes and 4 teaching schools. 

David is also Professor of Movement Disorders Neurology and Honorary Consultant Neurologist for Newcastle upon Tyne Hospitals NHS Foundation Trust.

After finishing his first degree at Oxford (Physiological Sciences), he returned to his native North East for clinical training and early medical jobs, including in neurology.

After further neurology training and undertaking research in London (at the National Hospital for Neurology and Neurosurgery, Queen Square and Hammersmith Hospital) he was appointed as a Consultant Neurologist and Senior Lecturer in Newcastle in 1994.  

David has an international reputation for research in dementia associated with Parkinson's.  He is an NIHR Senior Investigator and chairs the NIHR Translational Research Collaboration for Dementia.

He served on the Parkinson's UK Research Advisory Panel between 2006 and 2012. As National Clinical Director for the Parkinson's UK Excellence Network between 2014 and 2017, David worked with the Chief Executive and senior charity staff to devise and establish the network, drive innovation, and ensure delivery against key performance indicators.

Beyond this role, David felt highly motivated to retain his connection with Parkinson's UK and to continue to contribute towards delivering the charity's ambitious strategy.

Andrew Cavey

Andrew Cavey was co-opted to the Board of Trustees in August 2018. 

He works at Novartis, where he heads the company's clinical development efforts in benign haematology. His role is to help more patients gain access to new and innovative medicines for conditions such as sickle cell disease.

Andrew has spent his career in healthcare globally. He worked as a physician for the NHS in the UK and for a variety of non-governmental organisations in conflict and disaster settings in sub-Saharan Africa and Asia. 

He subsequently became a management consultant at McKinsey & Company, focusing on the pharmaceutical sector, before joining Novartis in various senior strategy and commercial roles in Switzerland and China. 

He holds medical and physiology degrees from Oxford University and a Masters in Public Health from Harvard. He lives with his wife and 2 sons in Switzerland. 

Margaret Chamberlain

Margaret Chamberlain was elected to the Board of Trustees in September 2013.

Margaret is a solicitor and a senior partner in a City law firm, with experience of dealing with government, large companies and regulators.

She is passionate about making sure that the voices of people affected by Parkinson's are heard by government, the medical profession and in research.

Margaret has supported Parkinson's UK for many years. Her mother had Parkinson's and she also has a close friend with early onset Parkinson's.

Matthew Durdy

Part of the team that created the Catapult programme, Matthew Durdy is also an executive director of the Cell and Gene Therapy Catapult. 

Matthew is responsible for finding, funding and transacting the business of the Catapult as well as the development of the overall strategy. 

He has been a champion of the early integration of healthcare economics and reimbursement expertise into decision-making and clinical product design in the sector. 

He began his career in international investment banking and has successfully managed a number of biotechnology SMEs. 

His first degree was from Oxford University in Biology and he has an MBA (High Honors) from the University of Chicago Booth School of Business. 

He is a non-executive director of an immuno-oncology company and periodically assists the government and international organisations in the development of initiatives in healthcare innovation. 

Freda Lewis (Trustee from Wales)

Freda Lewis was co-opted to the Board of Trustees in November 2015.

A trained nurse, midwife and health visitor, Freda is a former director of The Fostering Network for Wales and policy manager within the Welsh government. She has extensive experience of the health and social care sectors and the implications of devolution, including legislative differences.

Freda has an MSc in interprofessional studies, researching how professionals work together effectively, completing a dissertation on effective team work in primary care in 2000.

Freda has supported relatives diagnosed with Parkinson's and is keen to give her knowledge and experience to support people affected by the condition.

Anne MacColl (Trustee from Scotland)

Anne MacColl was co-opted as a Trustee in 2016.

Anne has had a successful career as an international executive with 10 years at executive leadership level and 12 years' experience living and working overseas.

She continues to work with a range of boards and executive teams in not for profit, public and commercial organisations.

She has held a variety of diverse positions in national and international commercial, public and academic organisations, including Chief Executive of Scottish Development International, Soluziona international consultants, and with the University of Stirling.

Anne's husband was diagnosed with Parkinson's at the age of 50 in 2014. Since then she has worked to support Parkinson's UK and its aims, through the Parkinson's UK Scotland team and through fundraising efforts, running several half marathons on behalf of the charity.

She currently holds non-executive positions with the Social Enterprise Academy, CEFAS and the Scottish Salmon Producers Organisation and also runs her own freelance consultancy business.

Richard Raine

Richard Raine was appointed to the Board of Trustees in September 2014.

Richard has been finance director of a number of companies, both private and stock exchange listed, covering a range of business sectors.

During the past few years he has worked on a consultancy and interim basis with many SMEs, largely in the private equity arena. He has significant experience in financial restructuring and corporate transactions.

He holds an MBA from Cranfield School of Management, is a graduate of Durham University and a chartered accountant.

Previously he has been a trustee and treasurer of Trinity Hospice for 9 years, and is a former director of the Fundraising Standards Board.

Richard lives in West London with his wife and 2 children.

Gary Shaughnessy

Gary Shaughnessy was elected to the Board of Trustees in August 2018.
 
Gary previously had a successful career in the insurance and financial services industry, working in senior roles within well-known British and international companies. Gary stepped down from his role as CEO Europe, Middle East and Africa for Zurich Insurance in October 2018. He will remain part of Zurich's Group Executive Team until the end of 2018.
 
Gary is a keen sportsman and played non-league football for many years. Since then he's combined sport and community engagement to raise funds and awareness for both local and national charities. Over the past few years he's thrown himself into wing walking and abseiling, as well as running numerous marathons. 

As Chairman of the Zurich's Community Trust he's engaged with companies, governments, charities and academic bodies to help tackle the growing impact of floods globally through early warning and prevention. He's also helped with highlighting the importance of wellbeing, particularly in a digitally enabled world, as well as with finding ways to increase inclusion at work.
 
Gary was diagnosed with Parkinson's in 2015. He's passionate about exercise, which he finds helps to limit the impact of the condition. He decided to step down from his role in Zurich to better balance work and non-executive roles, with spending more time on fitness and with family. He's also able to use his voice and experience to support increased awareness and action for people living with Parkinson's, their families and carers.

Gary is married with 3 children.

Tim Tamblyn

Tim Tamblyn was originally appointed as the interim Trustee from England in September 2014 but was later elected to this role in September 2015.

Tim is a chartered accountant and is a retired partner of the international accounting and consultancy organisation KPMG.

He is an experienced non-executive director and trustee, and has held non-executive positions in the voluntary sector in social housing, education and the NHS.

Tim cares passionately about the vulnerable people in our society and is a trustee and member of 2 national charities that support those with learning disabilities.

Tim was diagnosed with Parkinson's in 2012.

Paresh Thakrar

Paresh Thakrar is the Commercial Director of Brit Insurance. 

He was previously the COO of HiscoxRe and ILS, based in London, driving strategy, technology and operations for the business, and has been pivotal in bringing product, capital and tech innovation into the corporate DNA. 

Paresh began his career trading emerging markets securities at Deutsche Bank, followed by 7 years as a senior diplomat serving the government as a specialist in global security issues. 

He then worked at consultants McKinsey & Company where he served a range of investment and retail banks. 

Paresh holds a BA/MA from the University of Cambridge and an MBA from the London Business School.

Paul Warner

Paul Warner was elected to the Board of Trustees in October 2017.

He has an MBA from Henley Management College and is a graduate of the University of Liverpool.

Paul is a chartered accountant and has worked both in practice and industry, retiring from the position of finance director of an SME subsidiary of an international group.

His experience has been varied, covering both commercial operations as well finance.

He is the treasurer of his local Parkinson's UK branch as well as being a trustee of a pension scheme.

Paul was diagnosed with Parkinson's in 2013 and due to the issues he experienced during diagnosis and treatment he is dedicated to improving the services and support for other people living with Parkinson's.